Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Salestools Logo

Salestools

#1 AI-agent til salgsteams og Go-to-Market-teams. Sælg mere, hurtigere, med mindre indsats.

Produkt

  • AI-salgsagenter
  • Intent-data
  • Teknologidata
  • Besøgssporing
  • Co-Pilot
  • Socialt salg

Løsninger

  • Kundeservice
  • E-handel
  • SaaS
  • Enterprise
  • Lille virksomhed

Ressourcer

  • Rapporten
  • Dokumentation
  • API-reference
  • Hjælpecenter
  • Blog
  • Case-studier
  • Webinarer

Virksomhed

  • Om os
  • Karriere
  • Presse
  • Kontakt
  • Partnere

Vores lokationer

  • New York, HQ
  • Bukarest, AI-forskningslaboratorium
  • Zug, Schweiz

© 2025 Salestools. Alle rettigheder forbeholdes.

Datavilkår & sikkerhedPrivatlivspolitikServicevilkår
Alle systemer operationelle
Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Back to The Report
Fundraising

ZoomInfo

ZoomInfo Raises $200M in Series Unknown

2007
Founded
3000+
Employees
805 Broadway Street, Vancouver, WA 98660
Updated March 21, 2024
2 min read

Quick Facts

ZoomInfo Raises $200M in Series Unknown


ZoomInfo has successfully raised $200M in a Series Unknown at a $20B valuation led by TA Associates, The Carlyle Group, 22C Capital.


Company Overview


ZoomInfo is a Sales Tech company headquartered in 805 Broadway Street, Vancouver, WA 98660, founded in 2007 with 3000+ employees.


Go-to-market intelligence platform


Fundraising Details


  • Amount Raised: $200M
  • Round Type: Series Unknown
  • Valuation: $20B
  • Date: 2024-03-21
  • Investors: TA Associates, The Carlyle Group, 22C Capital

About ZoomInfo


Go-to-market intelligence platform The company is positioned in the Sales Tech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 805 Broadway Street, Vancouver, WA 98660
  • Founded: 2007
  • Team Size: 3000+
  • Industry: Sales Tech

What This Means


This funding round demonstrates strong investor confidence in ZoomInfo's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Sales Tech sector continues to attract significant investment as companies innovate to meet evolving market demands. ZoomInfo's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $20B valuation marks an important milestone for ZoomInfo, positioning the company among notable players in the Sales Tech industry.


Looking Ahead


With this new capital, ZoomInfo is well-positioned to execute on its growth strategy and continue building innovative solutions in the Sales Tech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-03-21. For more information about ZoomInfo, visit their headquarters at 805 Broadway Street, Vancouver, WA 98660.

Topics

Fundraising(2912)Sales TechSeries UnknownZoomInfo

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million